SYRA Syra Health Corp
Services-Employment Agencies · OTC · SEC CIK 1922335 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY19.5%
TTM net income YoY155.4%
TTM EPS YoY150.0%
Revenue 3-yr CAGR16.2%
Net income 3-yr CAGR—
Margins
Gross margin42.6%
Operating margin6.8%
Net margin7.8%
FCF margin—
EBITDA margin6.8%
Returns
ROE26.8%
ROA18.7%
ROIC (approx.)109.8%
Asset turnover2.39x
Leverage & solvency
Liabilities / assets28.4%
Debt / equity0.00x
Current ratio3.47x
Interest coverage58.86x
Cash quality & payout
Operating cash flow / net income0.98x
Accruals ratio0.4%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $7.23M | $7.98M | $5.52M | $5.62M |
| Cost of revenue | $4.74M | $6.33M | $4.10M | $4.56M |
| Gross profit | $2.49M | $1.65M | $1.41M | $1.06M |
| R&D expense | $67,840 | $585,146 | $240,048 | — |
| SG&A expense | $1.07M | $1.45M | $1.13M | $575,755 |
| Operating income | -$904,324 | -$3.76M | -$2.89M | -$2.09M |
| Interest expense | $13,270 | $15,600 | $53,686 | $28,533 |
| Net income | -$896,333 | -$3.76M | -$2.94M | -$2.12M |
| EBITDA | -$883,856 | -$3.70M | -$2.84M | -$2.07M |
| EPS (basic) | -0.08 | -0.50 | -0.60 | -0.70 |
| EPS (diluted) | -0.08 | -0.50 | -0.60 | -0.70 |
| Weighted avg. shares (diluted) | 11.85M | 7.55M | 4.88M | 3.04M |
| Balance sheet | ||||
| Cash & equivalents | $1.61M | $2.40M | $3.28M | $3,344 |
| Receivables | $918,374 | $680,827 | — | $1.20M |
| Current assets | $2.74M | $3.35M | $4.78M | $1.43M |
| PP&E, net | $6,986 | $27,347 | $78,974 | $112,493 |
| Total assets | $2.77M | $3.68M | $4.92M | $2.32M |
| Current liabilities | $674,739 | $613,549 | $910,072 | $1.55M |
| Total liabilities | $674,739 | $800,761 | $910,072 | $1.61M |
| Shareholders' equity | $2.10M | $2.88M | $4.01M | $710,098 |
| Cash flow statement | ||||
| Operating cash flow | -$447,746 | -$2.93M | -$2.76M | -$2.24M |
| Capital expenditure | $107 | $11,111 | $15,251 | $121,260 |
| Free cash flow | -$447,853 | -$2.94M | -$2.77M | -$2.37M |
| Investing cash flow | -$107 | -$11,111 | -$15,251 | -$121,260 |
| Financing cash flow | -$332,819 | $2.06M | $6.05M | $2.27M |
| Depreciation & amortization | $20,468 | $62,738 | $48,771 | $14,849 |
| Stock-based compensation | $98,554 | $59,803 | $32,831 | $2,910 |
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.